NBC News: Effects of psychedelic drugs can last for days or weeks, research finds
An off-duty Alaska Airlines pilot accused of trying to bring down a plane midflight said he had consumed “magic mushrooms” before boarding, bringing the use of psychedelic drugs as a treatment for mental illness into national headlines.
Psychedelics such as LSD, psilocybin found in magic mushrooms and MDMA are gaining increasing attention in scientific and medical circles because of the potential they hold for treating anxiety disorders and emotional trauma. Experts say the effects of psychedelics can last for days, weeks or longer after the substance is no longer detectable in the body.
The University of Cincinnati's Christopher Tuell, assistant professor of psychiatry and behavioral neuroscience in UC's College of Medicine and clinical director of addiction services at UC Health's Lindner Center of HOPE, spoke with NBC News about the use of psychedelics as mental health treatment.
Tuell said the brain develops habits that are key to survival, but sometimes the wiring results in unhealthy connections becoming strengthened, leading to issues including depression or anxiety. It’s like a car wheel stuck in a rut in the road, unable to pull out, Tuell said.
Psychedelics can help get the brain "unstuck" from this cycle of negative thoughts, moods and behaviors when used in the right context, experts say.
Read more about psychedelics research.
Featured photo at top of mushrooms. Photo/Christopher Ott/Unsplash.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.